BMJ Open (Jun 2024)

Photobiomodulation therapy for chronic knee pain in obese patients in pre-rehabilitation for bariatric surgery: randomised, placebo-controlled, double-blinded, clinical trial protocol

  • Rebeca Boltes Cecatto,
  • Maria Fernanda Setúbal Destro Rodrigues,
  • Ana Cristina Ferreira Garcia Amorim,
  • Thays C Flausino Belchior,
  • Tatiane Nunes da Silva Rodarte,
  • Francisco Albino Rebouças Junior,
  • Rodrigo Labat Marcos,
  • Adriana Lino-dos-Santos-Franco

DOI
https://doi.org/10.1136/bmjopen-2023-079864
Journal volume & issue
Vol. 14, no. 6

Abstract

Read online

Introduction Obesity has become a worldwide public health problem and is directly linked to loss of quality of life, complications and comorbidities. One of them is chronic pain, especially in the knees, which increases significantly and proportionally with weight gain. In patients with severe obesity, with indication for bariatric surgery, the presence of chronic pain disables and often prevents their participation in a pre-surgical rehabilitation programme. As an analgesic therapy, photobiomodulation (PBM) has been studied with safety, efficacy, well-tolerated used and low costs. Thus, this study aims to evaluate the use of PBM for the treatment of chronic knee pain in obese patients undergoing a pre-surgical rehabilitation programme for bariatric surgery.Methods and analyses This is a double-blinded, randomised, placebo-controlled clinical, superiority, trial protocol. The PBM will be applied in bilateral knees and lumbar paraspinal points levels referring to the roots of innervation of the knee. The outcomes evaluated will be pain intensity, functionality, quality of life and clinical signs of neurological sensitization of chronic knee pain pathways.Ethics and dissemination This protocol has already been approved by the Comitê de Ética em Pesquisa do Hospital das Clínicas da Universidade Federal de Goiás/EBSERH—Ethics Committee and it is following SPIRIT guidelines. The results will be statistically analysed and subsequently published in peer-reviewed journals.Trial registration number Clinical Trials Platform (https://clinicaltrials.gov/) with the number NCT05816798.